Efficacy and safety of combined immunotherapy and antiangiogenesis with or without chemotherapy for advanced non-small-cell lung cancer: A systematic review and pooled analysis from 23 prospective studies

• Main Authors: Ruo-Lin Gao (Author), Jun Song (Author), Li Sun (Author), Zhi-Xuan Wu (Author), Xiao-Fang Yi (Author), Shu-Ling Zhang (Author), Le-Tian Huang (Author), Jie-Tao Ma (Author), Cheng-Bo Han (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Purpose: Immune checkpoint and antiangiogenic inhibitors have a potentially synergistic antitumor effect. We aimed to assess the efficacy and safety of immunotherapy in combination with antiangiogenesis therapy with or without chemotherapy in patients with advanced non-small-cell lung cancer (NSCLC)...